This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elmer, G W
Right arrow Articles by McFarland, L V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elmer, G W
Right arrow Articles by McFarland, L V

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 January; 31(1): 129-131

Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.

G W Elmer and L V McFarland

ABSTRACT

Saccharomyces boulardii prevented the development of high counts of Clostridium difficile, high titers of toxin B, and positive latex agglutination tests after cessation of vancomycin treatment for hamsters. The protocol used was designed to stimulate relapse of human C. difficile-associated colitis. S. boulardii was protective in this model.

Antimicrob Agents Chemother. 1987 January; 31(1): 129-131




This article has been cited by other articles:

  • Qamar, A., Aboudola, S., Warny, M., Michetti, P., Pothoulakis, C., LaMont, J. T., Kelly, C. P. (2001). Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficile Toxin A in Mice. Infect. Immun. 69: 2762-2765 [Abstract] [Full Text]  
  • Castagliuolo, I., Riegler, M. F., Valenick, L., LaMont, J. T., Pothoulakis, C. (1999). Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa. Infect. Immun. 67: 302-307 [Abstract] [Full Text]  
  • McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Fekety, R., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K. E., Cox, J. L., Noorani, Z., Harrington, G., Rubin, M., Greenwald, D. (1994). A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease. JAMA 271: 1913-1918 [Abstract]  
  • Fekety, R., Shah, A. B. (1993). Diagnosis and Treatment of Clostridium difficile Colitis. JAMA 269: 71-75 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»